Safety and Immunogenicity of the Merck Adenovirus Serotype 5 (MRKAd5) and MRKAd6 Human Immunodeficiency Virus Type 1 Trigene Vaccines Alone and in Combination in Healthy Adults

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00473-09
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Immunogenicity of Multiple Gene and Clade Human Immunodeficiency Virus Type 1 DNA Vaccines

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

First-In-Human Phase 1 Trial of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 5 HVR48 (rAd5HVR48) HIV-1 Vaccine

Retrovirology
VirologyInfectious Diseases
2012English

Contribution of Virus-Like Particles to the Immunogenicity of Human Immunodeficiency Virus Type 1 Gag-Derived Vaccines in Mice

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2005English

The Safety and Immunogenicity of Two Novel Live Attenuated Monovalent (Serotype 2) Oral Poliovirus Vaccines in Healthy Adults: A Double-Blind, Single-Centre Phase 1 Study

The Lancet
Medicine
2019English

Interactions of Single and Combined Human Immunodeficiency Virus Type 1 (HIV-1) DNA Vaccines

Virology
Virology
2001English

Increased Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Gag Gene

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2000English

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 Gag Gene

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2003English

Safety and Pharmacokinetics of Abacavir (1592U89) Following Oral Administration of Escalating Single Doses in Human Immunodeficiency Virus Type 1-Infected Adults

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Safety, Pharmacokinetics, and Immunogenicity of the Combination of the Broadly Neutralizing Anti-Hiv-1 Antibodies 3BNC117 and 10-1074 in Healthy Adults: A Randomized, Phase 1 Study

PLoS ONE
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy